Propranolol for vascular anomalies: Efficacy and complications in pediatric patients

Conclusion: The study validates the use of propranolol hydrochloride as the first-line agent for the treatment of IHs and congenital hemangiomas. It may have an additive role in lymphatic malformations, and venous malformations, as a part of a multimodality treatment approach for vascular malformations.
Source: Journal of Indian Association of Pediatric Surgeons - Category: Surgery Authors: Source Type: research